Suppliers / Sichuan Long March Pharmaceutical

Sichuan Long March Pharmaceutical

China Updated 9 July 2026

Sichuan Long March Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files and 2 valid CEPs across a filed portfolio of 5 molecules.

2
active US DMFs
2
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Leshan, China Not on file

What they file, and where

Molecule Regulators Docs
Dihydrostreptomycin Sulfate For Veterinary Use EDQM 1
Framycetin SFDA (Saudi Arabia) 1
Neomycin EDQM 1
Oxytetracycline US FDA 1
Streptomycin US FDA 1

Also appears on these molecule pages

Questions about Sichuan Long March Pharmaceutical

Does Sichuan Long March Pharmaceutical hold a US DMF or a CEP?
Sichuan Long March Pharmaceutical holds 2 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Sichuan Long March Pharmaceutical manufacture?
1 registered site is on record, in China (Leshan). Every site is listed on this page with the register it came from.
What does Sichuan Long March Pharmaceutical make?
5 molecules are on record against Sichuan Long March Pharmaceutical, including Dihydrostreptomycin Sulfate For Veterinary Use, Framycetin, Neomycin and Oxytetracycline. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sichuan Long March Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability